MedTrace Logo

Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections

NCT01638039 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2012-07-11

No results posted yet for this study

Summary

The aim of this study is to accelerate the development of vaccine candidates against diarrheal diseases caused by Shigella and Enterotoxigenic Escherichia coli (ETEC). We plan to identify cases of laboratory-proven shigellosis and ETEC-associated diarrhea, to study humoral and cellular immune parameters following natural infections with Shigella and ETEC, and to compare the level of pre-existing local, humoral and cellular immune parameters in cases of shigellosis and ETEC-associated diarrhea and in matched controls.

Conditions

  • Dysentery

Interventions

OTHER

Laboratory Tests

Stool, blood, urine and saliva samples

Sponsors & Collaborators

Principal Investigators

  • Daniel Cohen, MPH, PhD · School of Public Health, Sackler Faculty of Medicine, Tel Aviv University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638039 on ClinicalTrials.gov